UTHR
#564
United Therapeutics Corporation - Common Stock
527.9 1 USD
+0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+2.17%
Monthly Change
+0.35%
6 month change
+3.60%
Year Change
+71.87%
Previous Close
516.6 8
Open
527.9 1
Low
527.9 1
High
527.9 1
Volume
98
Financials
- Market Capitalization 22.64 B
- Employee 1 400
- Founded 1996
- CEO N/A
- Website www.unither.com
- Headquarter Delaware, United States
- FIGI BBG000BV4XJ1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
19.41
Price to sales ratio
8.08
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 501 |  INSM Insmed Incorporated - Common Stock | 121.39 USD | -2.41% | -2.91% | +16.74% | -25.09% | 26.51 B USD | ||
| 511 |  INCY Incyte Corporation - Common Stock | 127.74 USD | -0.30% | +0.79% | -0.88% | +52.34% | 25.89 B USD | ||
| 675 |  JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 251.10 USD | +0.73% | +0.94% | -2.39% | +79.36% | 16.30 B USD | ||
| 697 |  ASND Ascendis Pharma A/S - American Depositary Shares | 249.36 USD | -0.36% | -2.48% | -2.19% | +21.59% | 15.45 B USD |
Frequently asked questions about United Therapeutics Corp
What is the United Therapeutics Corp stock price today?
The current price of United Therapeutics Corp (UTHR) is 527.91. Over the past 24 hours, the stock has changed by +2.17%. Follow the UTHR chart for real-time price dynamics.
What is the stock ticker of United Therapeutics Corp?
United Therapeutics Corp trades under the ticker UTHR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is United Therapeutics Corp stock going up?
UTHR has changed by +0.89% over the last week, +0.35% over the last month, and +71.87% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of United Therapeutics Corp?
United Therapeutics Corp currently has a market capitalization of 22.64 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were United Therapeutics Corp earnings last quarter?
Last quarter, United Therapeutics Corp reported earnings of 7.82 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was United Therapeutics Corp revenue for the last quarter?
United Therapeutics Corp reported quarterly revenue of 783.3 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was United Therapeutics Corp net income for the last quarter?
United Therapeutics Corp reported net income of 333 M for the last quarter. The previous quarter showed 274.9 M, which means net income changed by +21.13%.
How many employees does United Therapeutics Corp have?
As of the latest available data, United Therapeutics Corp has 1 400 employees. Workforce size can provide additional context about the company's scale and operations.
What is United Therapeutics Corp EBITDA?
United Therapeutics Corp EBITDA is 355 M, and its EBITDA margin is 45.32%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy United Therapeutics Corp stock?
You can buy United Therapeutics Corp (UTHR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in United Therapeutics Corp stock?
Investing in United Therapeutics Corp requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the UTHR chart and related analysis on metatrader.com as part of your research.